GEODE CAPITAL MANAGEMENT, LLC - SOPHIA GENETICS SA ownership

SOPHIA GENETICS SA's ticker is and the CUSIP is H82027105. A total of 35 filers reported holding SOPHIA GENETICS SA in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SOPHIA GENETICS SA
ValueSharesWeighting
Q3 2023$159,364
-32.2%
62,496
+19.2%
0.00%
Q2 2023$234,931
+10.0%
52,440
+22.0%
0.00%
Q1 2023$213,541
+508331.0%
42,966
+107.8%
0.00%
Q4 2022$42
-99.9%
20,6810.0%0.00%
Q3 2022$54,000
-27.0%
20,6810.0%0.00%
Q2 2022$74,000
-53.5%
20,6810.0%0.00%
Q1 2022$159,000
-15.9%
20,681
+53.6%
0.00%
Q4 2021$189,00013,4610.00%
Other shareholders
SOPHIA GENETICS SA shareholders Q2 2022
NameSharesValueWeighting ↓
PFM Health Sciences, LP 2,014,024$15,568,0000.58%
GENERATION INVESTMENT MANAGEMENT LLP 6,789,560$52,483,0000.24%
PURA VIDA INVESTMENTS, LLC 829,930$6,415,0000.21%
BANK PICTET & CIE (ASIA) LTD 64,420$498,0000.14%
BANQUE PICTET & CIE SA 2,096,420$16,205,0000.12%
Moloney Securities Asset Management, LLC 71,450$552,0000.11%
GENERAL ELECTRIC CO 1,111,111$8,588,8880.09%
Bank Pictet & Cie (Europe) AG 227,600$1,759,0000.07%
RTW INVESTMENTS, LP 226,589$1,752,0000.04%
DRIEHAUS CAPITAL MANAGEMENT LLC 287,406$2,222,0000.03%
View complete list of SOPHIA GENETICS SA shareholders